Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Deficit)
Beginning balances (in shares) at Dec. 31, 2020   57,152,000    
Beginning balances at Dec. 31, 2020 $ 316,997 $ 57 $ 319,582 $ (2,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   256,000    
Common stock issued upon warrant exercise 335   335  
Common stock issued upon cashless warrant exercise (in shares)   657,000    
Common stock issued upon cashless warrant exercise 0 $ 1 (1)  
Common stock issued upon exercise of options (in shares)   469,000    
Common stock issued upon exercise of options 1,754 $ 1 1,753  
Common stock issued upon cashless exercise of options (in shares)   325,000    
Common stock issued in connection with business combinations (in shares)   736,000    
Common stock issued in connection with business combinations 36,251 $ 1 36,250  
Common stock issued for assets (in shares)   300,000    
Common stock issued for services (in shares)   (90,000)    
Common stock issued for share based compensation (in shares)   (35,000)    
Common stock issued for share based compensation (3,734)   (3,734)  
Share based compensation 4,417   4,417  
Net income (loss) 16,887     16,887
Ending balances (in shares) at Sep. 30, 2021   59,770,000    
Ending balances at Sep. 30, 2021 372,907 $ 60 358,602 14,245
Beginning balances (in shares) at Jun. 30, 2021   59,562,000    
Beginning balances at Jun. 30, 2021 363,853 $ 60 353,575 10,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for share based compensation (in shares)   61,000    
Common stock issued for share based compensation 220   220  
Common stock issued upon cashless warrant exercise (in shares)   5,000    
Common stock issued upon exercise of options (in shares)   8,000    
Common stock issued upon exercise of options 22   22  
Common stock issued upon cashless exercise of options (in shares)   47,000    
Common stock issued in connection with business combinations (in shares)   87,000    
Common stock issued in connection with business combinations 3,063   3,063  
Share based compensation 1,722   1,722  
Net income (loss) 4,027     4,027
Ending balances (in shares) at Sep. 30, 2021   59,770,000    
Ending balances at Sep. 30, 2021 372,907 $ 60 358,602 14,245
Beginning balances (in shares) at Dec. 31, 2021   59,929,000    
Beginning balances at Dec. 31, 2021 371,291 $ 60 361,087 10,144
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for share based compensation (in shares)   255,000    
Common stock withheld for employee payroll taxes $ (1,465)   (1,465)  
Common stock issued upon cashless warrant exercise (in shares)   14,000    
Common stock issued upon exercise of options (in shares) 26,000      
Common stock issued upon cashless exercise of options (in shares)   12,000    
Common stock issued in connection with business combinations (in shares)   650,000    
Common stock issued in connection with business combinations $ 5,750 $ 1 5,749  
Share based compensation 3,793   3,793  
Net income (loss) (148,758)     (148,758)
Ending balances (in shares) at Sep. 30, 2022   60,860,000    
Ending balances at Sep. 30, 2022 230,611 $ 61 369,164 (138,614)
Beginning balances (in shares) at Jun. 30, 2022   60,782,000    
Beginning balances at Jun. 30, 2022 236,726 $ 61 368,077 (131,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for share based compensation (in shares)   78,000    
Common stock withheld for employee payroll taxes (17)   (17)  
Share based compensation 1,104   1,104  
Net income (loss) (7,202)     (7,202)
Ending balances (in shares) at Sep. 30, 2022   60,860,000    
Ending balances at Sep. 30, 2022 $ 230,611 $ 61 $ 369,164 $ (138,614)